Anna Nikkarinen
Doktorand vid Institutionen för immunologi, genetik och patologi; Forskningsprogram: Cancerprecisionsmedicin; Forskargrupp Ingrid Glimelius
- E-post:
- anna.nikkarinen@igp.uu.se
- Besöksadress:
- Akademiska sjukhuset, ingång 100/101
751 85 Uppsala - Postadress:
- Akademiska sjukhuset, ingång 100/101
751 85 Uppsala
Mer information visas för dig som medarbetare om du loggar in.
Kort presentation
Anna är onkolog och doktorand i Ingrid Glimelius forskargrupp vid IGP.
Hon bedriver translationell forskning på mantelcellslymfom, med fokus på tumörmikromiljö och genetik.
Nyckelord
- cancer genetics
- cancer immunotherapy
- makrofager
- mantelcellslymfom
Publikationer
Urval av publikationer
Senaste publikationer
- CD163+ macrophages in mantle cell lymphoma induce activation of prosurvival pathways and immune suppression (2024)
- Aplastic anemia triggered by the Bruton tyrosine kinase inhibitor acalabrutinib in two patients with mantle cell lymphoma (2024)
- Empowering macrophages (2024)
- Soluble CD163 predicts outcome in both chemoimmunotherapy and targeted therapy-treated mantle cell lymphoma (2023)
- Infiltration of CD163-, PD-L1-and FoxP3-positive cells adversely affects outcome in patients with mantle cell lymphoma independent of established risk factors (2021)
Alla publikationer
Artiklar
- CD163+ macrophages in mantle cell lymphoma induce activation of prosurvival pathways and immune suppression (2024)
- Aplastic anemia triggered by the Bruton tyrosine kinase inhibitor acalabrutinib in two patients with mantle cell lymphoma (2024)
- Empowering macrophages (2024)
- Soluble CD163 predicts outcome in both chemoimmunotherapy and targeted therapy-treated mantle cell lymphoma (2023)
- Infiltration of CD163-, PD-L1-and FoxP3-positive cells adversely affects outcome in patients with mantle cell lymphoma independent of established risk factors (2021)
